Inventor · disambiguated record
Adam B. Fisher
Also filed as: FISHER ADAM · FISHER ADAM B
10 granted patents·10 pending applications·59 citations·filing 2016–2023
87Inventor score
Top patents by PatentIndex Score
20 records- 0195US9889164B2Bacteria engineered to treat a disease or disorderSYNLOGIC INC·Filed 2016·Granted Feb 13, 2018·27 cites·20 claims
- 0294US11291693B2Bacteria engineered to treat metabolic diseasesSYNLOGIC OPERATING CO INC·Filed 2016·Granted Apr 5, 2022·9 cites·19 claims
- 0394US10933102B2Bacteria engineered to treat a disease or disorderSYNLOGIC OPERATING CO INC·Filed 2017·Granted Mar 2, 2021·7 cites·22 claims
- 0493US11471494B2Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cellsSYNLOGIC OPERATING CO INC·Filed 2018·Granted Oct 18, 2022·7 cites·10 claims
- 0591US11723932B2Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cellsSYNLOGIC OPERATING CO INC·Filed 2017·Granted Aug 15, 2023·5 cites·7 claims
- 0685US11879123B2Bacteria for the treatment of disordersSYNLOGIC OPERATING CO INC·Filed 2018·Granted Jan 23, 2024·4 cites·24 claims
- 0774US2024382536A1Bacteria engineered to treat a disease or disorderSYNLOGIC OPERATING CO INC·Filed 2023·Application pending·0 cites
- 0871US11896627B2Bacteria engineered to treat metabolic diseasesSYNLOGIC OPERATING CO INC·Filed 2022·Granted Feb 13, 2024·0 cites·22 claims
- 0969US2023226122A1Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cellsSYNLOGIC OPERATING CO INC·Filed 2022·Application pending·0 cites
- 1067US2024110192A1Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrierSYNLOGIC OPERATING CO INC·Filed 2023·Application pending·0 cites
- 1166US11883439B2Bacteria engineered to treat a disease or disorderSYNLOGIC OPERATING CO INC·Filed 2020·Granted Jan 30, 2024·0 cites·17 claims
- 1265US11384359B2Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrierSYNLOGIC OPERATING CO INC·Filed 2016·Granted Jul 12, 2022·0 cites·18 claims
- 1364US2024180974A1Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cellsSYNLOGIC OPERATING CO INC·Filed 2023·Application pending·0 cites
- 1459US2023332164A1Bacteria engineered to secrete active proteinsSYNLOGIC OPERATING CO INC·Filed 2021·Application pending·0 cites
- 1556US2023043588A1Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrierSYNLOGIC OPERATING CO INC·Filed 2022·Application pending·0 cites
- 1654US11685925B2Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrierSYNLOGIC OPERATING CO INC·Filed 2016·Granted Jun 27, 2023·0 cites·17 claims
- 1745US2020149053A1Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cellsSYNLOGIC OPERATING CO INC·Filed 2018·Application pending·0 cites
- 1843US2021161976A1Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrierSYNLOGIC OPERATING CO INC·Filed 2017·Application pending·0 cites
- 1939US2019010506A1Bacteria engineered to treat metabolic diseasesSYNLOGIC INC·Filed 2016·Application pending·0 cites
- 2038US2019282628A1Recombinant bacteria engineered to treat diseases and disorders associated with amino acid metabolism and methods of use thereofSYNLOGIC INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Adam B. Fisher files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →